Difference between revisions of "Team:Pasteur Paris/Overview"

Line 66: Line 66:
  
 
So our project consists on the development of a better mapping tool of vector-borne diseases to specifically target insecticide spreading in infected areas only, to facilitate rapid diagnosis, and significantly improve the prevention against these diseases before outbreak appearance. To do that we engineered a dual system capable for ensuring both the capture of mosquitoes and also the detection of the presence or absence of virus in these vectors. </br></br>
 
So our project consists on the development of a better mapping tool of vector-borne diseases to specifically target insecticide spreading in infected areas only, to facilitate rapid diagnosis, and significantly improve the prevention against these diseases before outbreak appearance. To do that we engineered a dual system capable for ensuring both the capture of mosquitoes and also the detection of the presence or absence of virus in these vectors. </br></br>
 
+
 +
Our solution is based on the use of synthetic biology to design the MOS (KIT) O patch. We produce from E. coli a novel fusion protein with 3 functions:</br>
 +
<img src="https://static.igem.org/mediawiki/2016/5/57/Our_Patch_pasteur.png" width="100%"  alt="image"/></img></br>
  
  
Line 72: Line 74:
  
  
This patch is customizable and can be easily adapted to simultaneously test for multiple vector-borne pathogens prevalent in specific locations. Additionally, the patch will have 2D barcoded readouts, generating an environmental surveillance database. A precise map of vector hot spots will provide a better assessment and response to vector-borne diseases, assisting local health authorities with anticipating and preparing for an epidemic.</br></br>
 
  
 +
As a result of these three functions, the protein is able to specifically catch viral proteins. And with a simple marking solution, it reveals the presence of the virus. Our novel protein is integrated into a cellulose patch giving a user friendly detection device. It is rigid, easy to be manipulated, and made from a new composite biomaterial. In addition, by choosing the antibody that we fix on the protein BpA, we choose the virus that we want to detect (Zika, Chikunguya, Dengue, Yellow Fever…).</br></br>
  
 
To learn more about the design of our patch with the production of this fusion protein, you can go to the <a href="https://2016.igem.org/Team:Pasteur_Paris/Science">Science</a> section.
 
To learn more about the design of our patch with the production of this fusion protein, you can go to the <a href="https://2016.igem.org/Team:Pasteur_Paris/Science">Science</a> section.

Revision as of 12:34, 6 October 2016